APA

Abu Jawdeh B. G., Woodle E. S., Leino A. D., Brailey P., Tremblay S., Dorst T., Abdallah M. H., Govil A., Byczkowski D., Misra H., Abuchowski A. & Alloway R. R. (20190528). A phase Ib, open-label, single arm study to assess the safety, pharmacokinetics, and impact on humoral sensitization of SANGUINATE infusion in patients with end-stage renal disease. : Clinical transplantation.

Chicago

Abu Jawdeh Bassam G, Woodle Ervin Steve, Leino Abbie D, Brailey Paul, Tremblay Simon, Dorst Tonya, Abdallah Mouhamad H, Govil Amit, Byczkowski Daniel, Misra Hemant, Abuchowski Abraham and Alloway Rita R. 20190528. A phase Ib, open-label, single arm study to assess the safety, pharmacokinetics, and impact on humoral sensitization of SANGUINATE infusion in patients with end-stage renal disease. : Clinical transplantation.

Harvard

Abu Jawdeh B. G., Woodle E. S., Leino A. D., Brailey P., Tremblay S., Dorst T., Abdallah M. H., Govil A., Byczkowski D., Misra H., Abuchowski A. and Alloway R. R. (20190528). A phase Ib, open-label, single arm study to assess the safety, pharmacokinetics, and impact on humoral sensitization of SANGUINATE infusion in patients with end-stage renal disease. : Clinical transplantation.

MLA

Abu Jawdeh Bassam G, Woodle Ervin Steve, Leino Abbie D, Brailey Paul, Tremblay Simon, Dorst Tonya, Abdallah Mouhamad H, Govil Amit, Byczkowski Daniel, Misra Hemant, Abuchowski Abraham and Alloway Rita R. A phase Ib, open-label, single arm study to assess the safety, pharmacokinetics, and impact on humoral sensitization of SANGUINATE infusion in patients with end-stage renal disease. : Clinical transplantation. 20190528.